HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Drug-associated polymyalgia rheumatica/giant cell arteritis occurring in two patients after treatment with ipilimumab, an antagonist of ctla-4.

AuthorsBarbara L Goldstein, Lydia Gedmintas, Derrick J Todd
JournalArthritis & rheumatology (Hoboken, N.J.) (Arthritis Rheumatol) Vol. 66 Issue 3 Pg. 768-9 (Mar 2014) ISSN: 2326-5205 [Electronic] United States
PMID24574239 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Ipilimumab
Topics
  • Antibodies, Monoclonal (adverse effects, therapeutic use)
  • Giant Cell Arteritis (chemically induced)
  • Humans
  • Ipilimumab
  • Male
  • Melanoma (drug therapy)
  • Middle Aged
  • Polymyalgia Rheumatica (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: